The PDE5 inhibitors sildenafil and tadalafil were found to reduce the proliferation and migration of thyroid cancer cells in vitro, suggesting that targeting PDE5 may be a potential treatment strategy for PTCs (49). The gene discussed is PDE5A; the disease is thyroid gland carcinoma.